Weaver C. Barksdale & Associates’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$19K Sell
161
-26
-14% -$2.69K 0.02% 164
2017
Q3
$18K Sell
187
-6
-3% -$534 0.02% 165
2017
Q2
$17K Buy
193
+5
+3% +$440 0.02% 173
2017
Q1
$17K Hold
188
– – 0.02% 175
2016
Q4
$16K Buy
188
+39
+26% +$3.48K 0.03% 189
2016
Q3
$13K Buy
149
+13
+10% +$1.3K 0.02% 206
2016
Q2
$14K Hold
136
– – 0.02% 174
2016
Q1
$14K Hold
136
– – 0.01% 200
2015
Q4
$12K Buy
136
+6
+5% +$535 0.01% 218
2015
Q3
$12K Buy
130
+5
+4% +$501 0.01% 218
2015
Q2
$13K Sell
125
-18
-13% -$1.8K 0.01% 217
2015
Q1
$13K Hold
143
– – 0.01% 225
2014
Q4
$12K Sell
143
-11
-7% -$888 0.01% 220
2014
Q3
$12K Sell
154
-16
-9% -$1.24K 0.01% 221
2014
Q2
$12K Buy
170
+23
+16% +$1.67K 0.01% 231
2014
Q1
$11K Sell
147
-6
-4% -$431 0.01% 233
2013
Q4
$11K Buy
153
+25
+20% +$1.78K 0.01% 250
2013
Q3
$10K Sell
128
-6
-4% -$439 0.01% 260
2013
Q2
$10K Buy
+134
New +$8.98K 0.01% 257

Other funds holding CRI

Weaver C. Barksdale & Associates's CRI Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Carter's (CRI) stake by 14% in Q4 2017, selling an estimated $2.69K and leaving 161 shares worth $19K. The position accounts for 0.02% of the portfolio, ranked #164.

Weaver C. Barksdale & Associates first reported a position in CRI in Q2 2013 and has held it in 19 quarters since. 351 funds tracked by Wall St. Rank hold CRI as of Q4 2017.

  • Weaver C. Barksdale & Associates held 161 shares of Carter's worth $19K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 26 Carter's shares in Q4 2017, an estimated $2.69K.
  • Carter's made up 0.02% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #164 holding.
  • Weaver C. Barksdale & Associates first reported a position in Carter's in Q2 2013 and has held it in 19 quarters since.
  • 351 funds tracked by Wall St. Rank held Carter's as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.